Annamarie Saarinen

Annamarie Saarinen is an accomplished leader in health policy and technology, currently serving as Co-founder of Bloom Standard, a medtech company focused on innovations for medically fragile children. Annamarie holds a position on the Advisory Committee on Heritable Disorders in Newborns and Children for the U.S. Department of Health and Human Services and is Co-Founder and Co-Chair of the Board for the Newborn Foundation, dedicated to enhancing health outcomes for newborns. Annamarie serves on multiple advisory boards, including the Newborn Screening Advisory Committee and the Pediatric Device Innovation Consortium. With extensive experience in health economics and public policy, Annamarie has held significant roles, including Health Economics & Outcomes Research at Masimo and Principal at Ainsley Shea. Annamarie's educational background includes advanced degrees in Economics from Iowa State University and a fellowship at the Yale School of Public Health.